PAR
Click for more information
0.00% 23.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-148

  1. Robbie1
    339 Posts.
    lightbulb Created with Sketch. 129
    clock Created with Sketch.
    03/11/21
    17:21
    Post #: 57291737
    Would be interested to see the coppo report today if anyone has access to it.

    Also i'm sure the valuations will be adjusted accordingly for the de-risking so the flow of updated analyst reports will be interesting to read.


    PAR Price at posting: $2.53 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
BOE Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $80.45M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 2421 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 659 1
View Market Depth
Last trade - 09.56am 06/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.